InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,246.68
(
0.48%
)
US TECH 100
17,844.00
(
0.68%
)
Dow Jones
39,558.11
(
0.32%
)
Brent Oil
82.74
(
0.22%
)
Bitcoin
61,823.06
(
0.45%
)
Post# of 251821
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11487
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: DewDiligence post# 189363

Monday, 03/30/2015 12:04:48 PM

Monday, March 30, 2015 12:04:48 PM

Post# of 251821

ABBV had a similar problem with Humira, but that’s well on its way to being rectified




You really think Abbv has the loss of Humeria sales covered? Everyone likes to claim that Copaxone represents a 50% portion of Teva's profits but isn't Humeria responsible for close to 65% of Abbvie's profits?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up